Filing Flows › Colgate Palmolive (CL) › Q2 2026 › vs Q2 2025
Colgate Palmolive (CL) Q2 2026 vs Q2 2025 (year over year)
Colgate Palmolive's revenue rose $251M (+5%) from $5.1B in Q2 2025 to $5.4B in Q2 2026. Gross margin 61.5% against 60.1% (+1.4 pts).
Colgate Palmolive, Q2 2026: revenue $5.4B (+5% year over year), operating margin 19.0%, net earnings $693M, operating cash flow $995M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 61.5% | 60.1% | +1.4 pts |
| Operating margin | 19.0% | 21.1% | -2.2 pts |
| Net margin | 12.9% | 14.5% | -1.6 pts |
| Free cash flow margin | 16.2% | 15.2% | +1.0 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5.4B | $5.1B | $251M | +5% |
| Gross profit | $3.3B | $3.1B | $227M | +7% |
| Cost of revenue | $2.1B | $2.0B | $24.0M | +1% |
| Operating profit | $1.0B | $1.1B | −$64.0M | -6% |
| Operating expenses | $2.3B | $2.0B | $291M | +15% |
| Pre-tax earnings | $950M | $1.0B | −$57.0M | -6% |
| Other expense, net | $66.0M | $73.0M | −$7.0M | -10% |
| SG&A | $2.1B | $2.0B | $167M | +9% |
| Other operating costs | $150M | $26.0M | $124M | +477% |
| Net earnings | $693M | $743M | −$50.0M | -7% |
| Minority interests | $26.0M | $30.0M | −$4.0M | -13% |
| Income tax | $231M | $234M | −$3.0M | -1% |
| Depreciation & amortization | $155M | $151M | $4.0M | +3% |
| Share-based compensation | $38.0M | $32.0M | $6.0M | +19% |
| Working capital & other | $109M | −$42.0M | $151M | — |
| Operating cash flow | $995M | $884M | $111M | +13% |
| Free cash flow (OCF − capex) | $867M | $776M | $91.0M | +12% |
| Capital expenditures | $128M | $108M | $20.0M | +19% |
Questions
How much did Colgate Palmolive's revenue grow year over year in Q2 2026?
Colgate Palmolive's revenue rose $251M (+5%) from $5.1B in Q2 2025 to $5.4B in Q2 2026. Gross margin 61.5% against 60.1% (+1.4 pts).